文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

高截留量对比标准血液滤过在重症急性肾损伤患者中的双盲随机对照试验

A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论在重症急性肾损伤伴升压药依赖患者中,高截留量血液滤过未缩短无去甲肾上腺素时间或降低死亡率,也未改变白蛋白水平。

该单中心双盲随机对照试验在澳大利亚三级医院ICU纳入76例升压药依赖的急性肾损伤患者,比较连续静脉-静脉血液滤过高截留量(CVVH-HCO)与标准截留量(CVVH-standard)。主要终点第7天无去甲肾上腺素时间中位数在高截留量组为32小时(0-110.8),标准组为56小时(0-109.3)(p=0.520)。院内死亡率高截留量组55.6% vs 标准组34.2%(校正OR 2.49;95%CI 0.81-7.66;p=0.191)。去甲肾上腺素停用时间、血液滤过停止时间、滤器寿命及白蛋白水平/用量均无显著差异。结论:高截留量血液滤过未减少升压药支持时间或死亡率,也未改变白蛋白水平。

要点

  • 在升压药依赖的急性肾损伤ICU患者中,高截留量血液滤过第7天无去甲肾上腺素时间中位数32小时(0-110.8),标准血液滤过56小时(0-109.3),p=0.520。
  • 院内死亡率高截留量组55.6% vs 标准组34.2%,校正OR 2.49(95%CI 0.81-7.66;p=0.191),未达统计学显著。
  • 去甲肾上腺素停用时间(p=0.358)、血液滤过停止时间(p=0.563)、滤器寿命(p=0.21)两组均无显著差异。
  • 血清白蛋白水平(p=0.192)及静脉白蛋白用量中位数高截留量组90克(20-212 g)vs 标准组80克(15-132 g)(p=0.252)无显著差异。
  • 高截留量血液滤过未缩短升压药支持时间或降低死亡率,也未改变白蛋白水平。

适用人群与场景

  • ICU收治的升压药依赖的急性肾损伤患者。

处置流程与药物剂量

  • 随机分配至连续静脉-静脉血液滤过高截留量或连续静脉-静脉血液滤过标准截留量。

研究设计与关键结果

  • 单中心双盲随机对照试验,共76例患者,高截留量组 vs 标准组:中位年龄65 vs 70岁,男性比例47% vs 68%,中位APACHE评分25 vs 23.5。
  • 主要终点第7天无去甲肾上腺素时间中位数:高截留量组32小时(0-110.8) vs 标准组56小时(0-109.3),p=0.520。
  • 院内死亡率:高截留量组55.6% vs 标准组34.2%,校正OR 2.49(95%CI 0.81-7.66;p=0.191)。
  • 去甲肾上腺素停用时间(p=0.358)、血液滤过停止时间(p=0.563)、滤器寿命(p=0.21)无显著差异。
  • 血清白蛋白水平(p=0.192)相似;静脉白蛋白用量中位数高截留量组90克(20-212 g) vs 标准组80克(15-132 g),p=0.252。

证据类型、等级与局限

  • 证据类型:单中心双盲随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在重症急性肾损伤升压药依赖患者中,高截留量血液滤过未减少升压药支持时间或死亡率,也未改变白蛋白水平。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: In critically ill patients with acute kidney injury receiving vasopressors, high cytokine levels may sustain the shock state. High cutoff hemofiltration achieves greater cytokine removal in ex vivo and in animal models and may reduce the duration of shock but may also increase albumin losses.

DESIGN: This was a single-center double-blind randomized controlled trial comparing continuous venovenous hemofiltration-high cutoff to continuous venovenous hemofiltration-standard.

SETTING: Tertiary care hospital in Australia.

PATIENTS: Vasopressor-dependent patients in acute kidney injury who were admitted to the ICU.

INTERVENTIONS: Norepinephrine-free time were calculated in critically ill vasopressor-dependent patients in acute kidney injury, randomized to either continuous venovenous hemofiltration-high cutoff or continuous venovenous hemofiltration-standard.

MEASUREMENT AND MAIN RESULTS: A total of 76 patients were randomized with the following characteristics (continuous venovenous hemofiltration-high cutoff vs continuous venovenous hemofiltration-standard); median age of 65 versus 70 year, percentage of males 47% versus 68%, and median Acute Physiology and Chronic Health Evaluation scores of 25 versus 23.5. The median hours of norepinephrine-free time at day 7 were 32 (0-110.8) for continuous venovenous hemofiltration-high cutoff and 56 hours (0-109.3 hr) (p = 0.520) for continuous venovenous hemofiltration-standard. Inhospital mortality was 55.6% with continuous venovenous hemofiltration-high cutoff versus 34.2% with continuous venovenous hemofiltration-standard (adjusted odds ratio, 2.49; 95% CI, 0.81-7.66; p = 0.191). There was no significant difference in time to cessation of norepinephrine (p = 0.358), time to cessation of hemofiltration (p = 0.563), and filter life (p = 0.21). Serum albumin levels (p = 0.192) were similar and the median dose of IV albumin given was 90 grams (20-212 g) for continuous venovenous hemofiltration-high cutoff and 80 grams (15-132 g) for continuous venovenous hemofiltration-standard (p = 0.252).

CONCLUSIONS: In critically ill patients with acute kidney injury, continuous venovenous hemofiltration-high cutoff did not reduce the duration of vasopressor support or mortality or change albumin levels compared with continuous venovenous hemofiltration-standard.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Atan R, Peck L, Prowle J, et al. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury. Crit Care Med. 2018. PMID: 30074491. doi:10.1097/CCM.0000000000003350

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。